The Utility of Breath Biopsy as a Screening Tool for HCC (BrtH-C)
The Utility of Breath Biopsy as a Screening Tool for HCC: A Pilot Study
Sponsor: University of Aberdeen
Listed as NCT04326491, this observational or N/A phase trial focuses on Cirrhosis, Liver and HCC and remains completed. Sponsored by University of Aberdeen, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2022 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Apr 2022 — Jun 2022 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Apr 2022 [monthly]
Not Yet Recruiting
▶ Show 1 earlier version
-
Apr 2020 — Jan 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Aberdeen
For direct contact, visit the study record on ClinicalTrials.gov .